The Effect of Graded Forced Expiration on Intraocular Pressure
1 other identifier
interventional
60
1 country
1
Brief Summary
The primary objective of this study is to utilize the Airofit device to systematically measure and characterize the changes in intraocular pressure across its six different levels of forced expiration. This investigation will provide crucial quantitative data on the IOP-respiratory effort relationship, enhancing our understanding of IOP dynamics during controlled respiratory stress and establishing a new, standardized paradigm for such research.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 27, 2025
CompletedFirst Posted
Study publicly available on registry
December 10, 2025
CompletedStudy Start
First participant enrolled
December 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 10, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 25, 2026
CompletedDecember 22, 2025
December 1, 2025
2 months
November 27, 2025
December 15, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Intraocular Pressure Measurement
The intraocular pressure will be measured in both eyes using a calibrated Tonoref III non-contact tonometry (Nidek Co., Ltd., Gamagori, Aichi, Japan) and applanation tonometry (A900 tonometer, Costruzione Strumenti Oftalmici, Firenze, Italy) by a single examiner
T0: Baseline / T1: after 1 minute of forced expiration at Level 1 /T2: after 1 minute of forced expiration at Level 2/T3: Immediately after 1 minute of forced expiration at Level 3
Study Arms (1)
Forced expiration program
EXPERIMENTALThe participants will be equipped with the Airofit respiratory muscle trainer and will be provided with standardised instructions on performing forced expiration manoeuvres. Participants will be fitted with the Airofit respiratory muscle trainer and given standardized instructions on performing forced expiration maneuvers. * The protocol consisted of sequentially performing forced expiration at each of the device's six predefined resistance levels (Level 1 being the lowest, Level 6 the highest). * The sequence for each level will be identical and as follows: * Exercise Phase: The participant will perform forced expiration maneuvers with the Airofit device for a duration of 5 minute at the specified resistance level. * Immediate Post-Exercise Measurement: Within 5 seconds of completing the exercise minute, IOP will be measured. This measurement will be labeled accordingly: T1 (after Level 1), T2 (after Level 2), up to T6 (after Level 6).
Interventions
The experiment will entail the acquisition of a total of seven intraocular pressure (IOP) measurements from each subject. * T0: Baseline (pre-intervention, resting). * T1: Immediately after 1 minute of forced expiration at Level 1. * T2: Immediately after 1 minute of forced expiration at Level 2. * T3: Immediately after 1 minute of forced expiration at Level 3. * T4: Immediately after 1 minute of forced expiration at Level 4. * T5: Immediately after 1 minute of forced expiration at Level 5. * T6: Immediately after 1 minute of forced expiration at Level 6.
Eligibility Criteria
You may qualify if:
- Aged 18 years or older.
- Willing and able to provide informed consent.
- Have a best-corrected visual acuity of 6/12 or better.
- Able to understand and follow instructions for using the Airofit device.
- Have an optic nerve cup/disc ratio not exceeding 0.5, and have a c/d difference between both eyes not exceeding 0.2.
- Did not have taken any anticholinergic medication, systemic beta-blockers, or corticosteroids within the last 3 months that could affect intraocular pressure levels.
You may not qualify if:
- a history of intraocular surgery,
- a history of uveitis,
- a spherical refractive error exceeding 3D,
- a history of regular topical treatment other than artificial tears
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Uşak Universitylead
Study Sites (1)
University of Usak
Uşak, 64200, Turkey (Türkiye)
Study Officials
- STUDY CHAIR
Ali Y Karahan, Prof.
University of Usak
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 27, 2025
First Posted
December 10, 2025
Study Start
December 15, 2025
Primary Completion
February 10, 2026
Study Completion
February 25, 2026
Last Updated
December 22, 2025
Record last verified: 2025-12